Prescription Required.
Treatment of acute diarrhea in adults and children over 3 months of age.
Zomatril Dt 100mg Tab (Racecadotril) is a selective inhibitor of enkephalinase, an enzyme that breaks down enkephalins. Enkephalins are natural pain-relieving substances that also play a role in regulating intestinal motility. By inhibiting enkephalinase, racecadotril increases the levels of enkephalins in the gut, which helps to reduce diarrhea by slowing down intestinal transit time and reducing fluid secretion.
Store at room temperature (15-30°C). Protect from light and moisture. Keep out of reach of children.
The dosage of racecadotril varies depending on age and severity of diarrhea.
Adults and children over 12 years: 100mg three times daily.
Children 3 months to 12 years: Dosage is based on body weight and should be determined by a healthcare professional.
Take the medication with or without food.
The duration of treatment should not exceed 3 days without consulting a doctor.
Do not exceed the recommended dosage.
Nausea
Vomiting
Abdominal pain
Constipation
Headache
Dizziness
Allergic reactions (rash, itching, swelling)
Avoid alcohol consumption while taking racecadotril, as it can increase the risk of side effects.
Racecadotril may cause dizziness or drowsiness. If you experience these side effects, avoid driving or operating machinery.
Racecadotril is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Consult a doctor before using this medication if you are pregnant or breastfeeding.
Racecadotril is not recommended for children under 3 months of age. Dosage for children 3 months to 12 years should be determined by a healthcare professional.
Racecadotril is not recommended for patients with severe kidney problems. Consult a doctor before using this medication if you have kidney problems.
Racecadotril is not recommended for patients with severe liver problems. Consult a doctor before using this medication if you have liver problems.
Summary of Product Characteristics (SmPC) for the specific racecadotril formulation
National Institutes of Health (NIH) website
Food and Drug Administration (FDA) website
